Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results.
Saved in:
| Title: | Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results. |
|---|---|
| Authors: | Oey A; Janssen Research & Development, LLC, South San Francisco, California, United States of America., McClure M; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Symons JA; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Chanda S; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Fry J; Janssen Research & Development, LLC, South San Francisco, California, United States of America., Smith PF; Certara Strategic Consulting, Parsippany, New Jersey, United States of America., Luciani K; Department of Infectious Diseases Hospital de Especialidades Pediátricas Omar Torrijos Herrera, Panama City, Panama., Fayon M; CHU de Bordeaux, Pneumologie pédiatrique, CIC 1401 (INSERM), Hôpital Pellegrin-Enfants, Bordeaux Cedex, France., Chokephaibulkit K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Uppala R; Department of Pediatrics, Khon Kaen University, Khon Kaen, Thailand., Bernatoniene J; Paediatric Infectious Disease and Immunology Department, Bristol Royal Hospital for Children, Bristol, United Kingdom., Furuno K; General Pediatrics & Interdisciplinary Medicine Fukuoka Children's Hospital, Fukuoka, Japan., Stanley T; Department of Paediatrics, University of Otago, Wellington, New Zealand., Huntjens D; Janssen Research & Development, Beerse, Belgium., Witek J; Janssen Research & Development, LLC, Titusville, New Jersey, United States of America. |
| Corporate Authors: | 503 and RSV2004 Study Groups |
| Source: | PloS one [PLoS One] 2023 Jul 19; Vol. 18 (7), pp. e0288271. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023). |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0288271 |
